Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy

Dendritic cells (DCs) are central players in the immune system, with an exquisite capacity to initiate and modulate immune responses. These functional characteristics have led to intense research on the development of DC-based immunotherapies, particularly for oncologic diseases. During recent decad...

Descripción completa

Detalles Bibliográficos
Autores principales: Calmeiro, João, Carrascal, Mylène, Gomes, Célia, Falcão, Amílcar, Cruz, Maria Teresa, Neves, Bruno Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727507/
https://www.ncbi.nlm.nih.gov/pubmed/31484548
http://dx.doi.org/10.1186/s40425-019-0716-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727507/
https://www.ncbi.nlm.nih.gov/pubmed/31484548
http://dx.doi.org/10.1186/s40425-019-0716-8

Ejemplares similares